Yatharth Hospital and Trauma Care Services Limited (IN:YATHARTH)
:YATHARTH
Top Page
Yatharth Hospital and Trauma Care Services Limited
(YATHARTH)
Select Model
Select Model
Rating:66Neutral
Price Target:
₹667.00
▼(-4.69% Downside)
Action:DowngradedDate:11/30/25
Yatharth Hospital's strong financial performance, characterized by revenue growth and improved profitability, is the most significant factor driving the stock score. However, technical indicators suggest short-term bearish momentum, and the high P/E ratio points to potential overvaluation. The absence of earnings call insights and corporate events limits the analysis to these core components.
Positive Factors
Strong revenue growth
Sustained ~32% revenue growth signals durable demand and successful expansion of service volumes. For a multi‑specialty hospital operator, high top‑line momentum typically reflects rising patient volumes, better case mix and scaling of fixed-cost infrastructure, supporting continued earnings growth over months.
Negative Factors
Negative free cash flow from capex
Ongoing negative free cash flow driven by heavy capex indicates growth is being funded internally at the expense of cash generation. If revenue or margin momentum slows, the need for external financing or equity dilution increases, which could constrain strategic flexibility over the next several quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong revenue growth
Sustained ~32% revenue growth signals durable demand and successful expansion of service volumes. For a multi‑specialty hospital operator, high top‑line momentum typically reflects rising patient volumes, better case mix and scaling of fixed-cost infrastructure, supporting continued earnings growth over months.
Read all positive factors
Yatharth Hospital and Trauma Care Services Limited (YATHARTH) vs. iShares MSCI India ETF (INDA)
Market Cap
₹67.91B
Dividend YieldN/A
Average Volume (3M)28.98K
Price to Earnings (P/E)36.2
Beta (1Y)1.16
Revenue Growth27.65%
EPS Growth4.02%
CountryIN
Employees3,607
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)4.50
Shares Outstanding96,354,355
10 Day Avg. Volume38,534
30 Day Avg. Volume28,985
Financial Highlights & Ratios
PEG Ratio15.52
Price to Book (P/B)2.27
Price to Sales (P/S)4.14
P/FCF Ratio-22.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)27.7
Revenue Forecast (FY)₹16.22B
Yatharth Hospital and Trauma Care Services Limited Business Overview & Revenue Model
Company Description
Yatharth Hospital & Trauma Care Services Limited owns and operates super-specialty hospitals in Delhi and Madhya Pradesh. The company offers services in the areas of gynecology; gastroenterology; pulmonology; pediatric; nephrology and urology; car...
How the Company Makes Money
The company primarily earns revenue by delivering hospital and clinical services to patients through its multi-specialty hospitals. Key revenue streams typically include: (1) Inpatient services (IPD), where revenue is generated from room/bed charg...
Yatharth Hospital and Trauma Care Services Limited Financial Statement Overview
Summary
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
72
Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.88B | 8.80B | 6.71B | 5.20B | 4.01B | 2.29B |
| Gross Profit | 6.73B | 5.39B | 5.37B | 4.27B | 3.20B | 1.82B |
| EBITDA | 2.69B | 2.36B | 1.96B | 1.37B | 1.13B | 675.27M |
| Net Income | 1.52B | 1.31B | 1.14B | 657.68M | 441.62M | 181.60M |
Balance Sheet | ||||||
| Total Assets | 18.56B | 17.31B | 10.19B | 4.86B | 4.26B | 3.09B |
| Cash, Cash Equivalents and Short-Term Investments | 2.83B | 5.15B | 2.39B | 382.36M | 120.31M | 51.52M |
| Total Debt | 262.33M | 115.86M | 846.47M | 2.67B | 2.64B | 1.93B |
| Total Liabilities | 1.36B | 940.45M | 1.45B | 3.03B | 3.09B | 2.28B |
| Stockholders Equity | 16.89B | 16.05B | 8.74B | 1.83B | 1.17B | 724.55M |
Cash Flow | ||||||
| Free Cash Flow | -1.49B | -1.61B | -964.43M | 439.70M | 468.01M | 235.38M |
| Operating Cash Flow | 485.14M | 1.50B | -30.78M | 637.84M | 599.35M | 436.73M |
| Investing Cash Flow | -2.51B | -4.20B | -2.26B | -203.10M | -521.75M | -212.38M |
| Financing Cash Flow | 142.57M | 5.19B | 3.04B | -177.48M | -11.24M | -190.50M |
Yatharth Hospital and Trauma Care Services Limited Technical Analysis
Positive
699.80
Price Trends
655.93
Positive
677.49
Positive
690.85
Positive
Market Momentum
2.38
Negative
59.95
Neutral
83.03
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:YATHARTH, the sentiment is Positive. The current price of 699.8 is above the 20-day moving average (MA) of 661.21, above the 50-day MA of 655.93, and above the 200-day MA of 690.85, indicating a bullish trend. The MACD of 2.38 indicates Negative momentum. The RSI at 59.95 is Neutral, neither overbought nor oversold. The STOCH value of 83.03 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:YATHARTH.
Yatharth Hospital and Trauma Care Services Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | ₹81.39B | -247.47 | ― | ― | 17.58% | -38.20% | |
66 Neutral | ₹67.91B | 36.23 | ― | ― | 27.65% | 4.02% | |
65 Neutral | ₹265.21B | 114.01 | ― | ― | 25.74% | 1.41% | |
64 Neutral | ₹39.43B | 25.06 | ― | 0.96% | 6.51% | 18.24% | |
62 Neutral | ₹346.18B | 151.95 | ― | 0.84% | -36.14% | -93.99% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | ₹16.31B | 310.39 | ― | 0.59% | 11.49% | -91.65% |
* Healthcare Sector Average
IN:YATHARTH
Yatharth Hospital and Trauma Care Services Limited
704.75
251.90
55.63%
IN:ASTERDM
Aster DM Healthcare Ltd.
668.15
168.18
33.64%
IN:HCG
HealthCare Global Enterprises Ltd.
545.15
22.83
4.37%
IN:INDRAMEDCO
Indraprastha Medical Corporation Limited
430.15
32.36
8.13%
IN:KIMS
Krishna Institute of Medical Sciences Limited
662.80
48.05
7.82%
IN:SHALBY
Shalby Ltd.
151.00
-37.85
-20.04%
Yatharth Hospital and Trauma Care Services Limited Corporate Events
Yatharth Hospital Updates Key Executives Authorized to Determine Material Disclosures
Feb 25, 2026
Yatharth Hospital and Trauma Care Services has updated its list of key managerial and senior management personnel authorized to determine the materiality of events and information for stock exchange disclosures. The newly designated officials, led...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.